Home
News & Events
News
122
Results found
-
A welcome to Marjon Pasmooij
It’s good to welcome Marjon Pasmooij as the latest member of the RSNN Steering Committee. We asked her to discuss how she sees the role of RSNN, and what challenges come next for regulatory science. -
Regulatory Science Magazine 7: advanced therapies and regulatory science in 2025
The MEB, the Dutch medicines authority, publishes the seventh edition of its Regulatory Science Magazine today. This edition focuses on the MEB science day and advanced therapies (ATMPs). There is also a piece about the vision document recently published by the European Medicines Agency (EMA) on the future for regulatory science up to 2025. -
Looking back and looking forward
In 2018, RSNN further expanded its network and activities. 2019 promises to be an exciting year in which RSNN activities will expand further, with an increased focus on international connections and delivering results. RSNN is expecting to attract new members who want to contribute to its mission to advance the regulatory system. -
RSNN Newsletter 6: December 2018
With the sixth edition of the RSNN newsletter, a new look is introduced. In this edition, we report on the RSNN sessions during the FIGON Dutch Medicines Days and Christine Gispen-de Wied shares her thoughts on what regulatory science has achieved to date, and what lies ahead. This and more regulatory science news and events can be found in the current RSNN newsletter. -
A forum for discussion: "The emergence of regulatory science gave us the opportunity to reach out to others"
Christine Gispen-de Wied is stepping down as Vice-Chair of the RSNN, after three years in the role. She shared her thoughts on what regulatory science has achieved to date, and what lies ahead. -
Evidence generation for innovative products in oncology
In the RSNN afternoon session of the FIGON Dutch Medicines Days, future evidence generation strategies were discussed. -
Focus on paediatric medicines in 6th edition of MEB’s Regulatory Science Magazine
Last week, the Medicines Evaluation Board (MEB) launched its 6th edition of the Regulatory Science Magazine. -
Regulatory challenges for the next wave of cancer therapies
In the RSNN morning session of the FIGON Dutch Medicines Days speakers from different perspectives presented their views on the challenges that come with the development of innovative oncology treatments. -
RSNN at EMA ‘Regulatory Science to 2025’ stakeholder consultation
To advance its engagement with regulatory science, the EMA gathered insights from stakeholders during a workshop on October 24. -
Looking back: Regulatory Science at the Partnerships MeetUp 2018
Regulatory science was an important topic during the Partnerships MeetUp on November 1st. -
Early stage cooperation between patients, developers, regulators and HTA bodies is critical for success in cancer treatment development
During the FIGON Dutch Medicines Days on October 1-2, the RSNN organized two regulatory science sessions around novel cancer treatments and the associated regulatory challenges. We look back at engaging presentations and discussions with a large, varied group of stakeholders. -
RSNN Newsletter 5: September 2018
The fifth RSNN newsletter is out now! In this edition we report on the RSNN Workshop ‘What’s in, What’s out, What’s relevant? – Towards a sensible label’ held on June 20th 2018, and announce upcoming meetings. -
Adaptive Pathways in Nature Reviews Drug Discovery
Earlier this month, Nature Reviews Drug Discovery (NRDD) published an article about Medicines Adaptive Pathways to Patients' (MAPPs). MAPPs seek to foster access to novel beneficial treatments for the right patient groups at the earliest appropriate time in the product life-span, in a sustainable fashion. -
RSNN Newsletter 4: Winter 2017
In this edition, we report on the Regulatory Science session on disease interception (BOX 3) held at the FIGON Dutch Medicines Days on October 2, 2017. In the morning, three excellent academic speakers provided examples of disease interception opportunities. In the afternoon, two speakers shared the industry and regulatory positions on disease interception. -
RSNN Newsletter 3: Summer 2017
In this edition you will find a first impression of the RSNN Workshop ‘Beyond the current clinical endpoints’ held on July 6, 2017, and announcements of upcoming meetings. We also present the standing executive - and steering committee of the RSNN.